Citi analyst Joanne Wuensch maintains $Edwards Lifesciences (EW.US)$ with a buy rating, and adjusts the target price from $83 to $77.
According to TipRanks data, the analyst has a success rate of 64.0% and a total average return of 6.4% over the past year.
Furthermore, according to the comprehensive report, the opinions of $Edwards Lifesciences (EW.US)$'s main analysts recently are as follows:
The analyst expresses uncertainty regarding the sustainability of the recent surge in medical technology stocks as the industry approaches the third-quarter financial disclosures. A cautious stance is adopted entering the earnings season, with the third quarter traditionally posing as the most challenging period for the MedTech sector due to the focus on the 2025 outlook and the potential influence of projections for the upcoming year on short-term stock performance.
The expectation for MedTech is a continued positive utilization trend into Q3, with a 'healthy' capital expenditure outlook anticipated for the following year. Meanwhile, in life science tools, bioprocess trends are expected to show improvement in the second half. However, there is ongoing discussion regarding the outlook for instruments and the impact of China's stimulus, especially considering the recent performance of stocks in this sector.
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
